Skip to main content
Clinical Trials/NCT07239856
NCT07239856RecruitingNot Applicable

Digestive Tolerance and Nutrient Absorption Kinetics of Goat Milk Versus Cow Milk in Individuals With Reported Cow's Milk Intolerance : a Controlled Single-blinded Crossover Trial

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement1 site in 1 country20 target enrollmentStarted: September 25, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
20
Locations
1
Primary Endpoint
Digestive discomfort score from 0 to 8 hours post-meal

Study Overview

Brief Summary

The objective of this study is to assess to what extent goat's milk is better tolerated than cow's milk among individuals who report being intolerant to cow's milk, and, if so, to understand the underlying factors. To achieve this, digestive discomfort sensations and postprandial kinetics of nutrients after ingestion of cow's or goat's milk will be compared in two populations: individuals intolerant to cow's milk but not to goat's milk, and individuals who show no symptoms of intolerance to either cow's or goat's milk. For this purpose, approaches based on stable isotope labeling of milk will be employed.

Detailed Description

Objective:

Although milk has many nutritional benefits, such as being rich in high-quality proteins and calcium, some people limit or exclude its consumption due to poor digestive tolerance. Lactose intolerance is a well-known cause, but other factors may occur, remaining poorly understood. Goat milk is perceived by consumers as causing fewer intestinal issues than cow milk, particularly for sensitive individuals. However, there is little scientific evidence to support this perception and to confirm the supposed health benefits of goat's milk over cow's milk. The objective of this study is to assess to what extent goat's milk is better tolerated than cow's milk among individuals who report being intolerant to cow's milk, and, if so, to understand the underlying factors.

Design:

This study is crossover study, randomized for the order of testing (goat milk or cow milk), conducted in a single-blind design (participants are not informed about the test meal, which is masked by aroma), involving two groups of at least ten volunteers: individuals intolerant to cow's milk but not to goat's milk, and individuals who show no symptoms of intolerance to either cow's or goat's milk. Each subject will have consumed both milks at the end of the two sessions, with a minimum one-month interval.

Postprandial Test Procedure:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Individuals who report being intolerant to cow milk but not to goat milk (one group) or tolerant to both cow milk and goat milk (another group)
  • •Good general health (WHO grade = 0)
  • •Affiliated with a social security scheme
  • •Free, informed, and express consent, in accordance with the public health code: 'No research mentioned in 2° of Article L. 1121-1 can be conducted on a person without their free, informed, and express consent.

Exclusion Criteria

  • •Individuals under guardianship or curatorship
  • •Individuals under legal protection
  • •Any known food allergies
  • •Anemia: hemoglobin levels below 13 g/dL for men and 12 g/dL for women
  • •Pregnant women or those likely to be (based on a positive urine pregnancy test at the time of inclusion)
  • •Excessive alcohol consumption (>2 drinks/day). Harmful alcohol consumption is assessed by the investigator at the time of inclusion.
  • •Hypertension, diabetes, digestive tract diseases (except for irritable bowel syndrome, IBS), liver or kidney diseases, severe heart disease. The presence of these conditions will be assessed by the investigator based on usual clinical criteria and the volunteers' declarations during inclusion. Hypertension: Significant arterial hypertension as determined by the investigator or systolic blood pressure greater than or equal to 140 mmHg and/or diastolic blood pressure greater than or equal to 90 mmHg on the day of inclusion. Diabetes: Type 1 or Type 2 diabetes or any fasting blood glucose level > 1.25 g/l. Digestive tract disease: Gastrointestinal disorders deemed by the investigator as clinically significant (bleeding, vomiting, constipation/diarrhea grade >1), any inflammatory bowel disease, acute gastroenteritis in the month preceding the intervention. Liver disease: Any significant liver disorder as determined by the investigator or any AST/ALT > 2.5 times the upper normal limit.
  • •Elite athletes (> 8 hours per week)
  • •Blood donation in the 3 months preceding the start of the study
  • •Participation in a clinical study in the 3 months preceding the study
  • •Lack of free, informed, and express consent

Arms & Interventions

Control

Experimental

Individuals who report being tolerant to both cow's milk and goat's milk.

Intervention: Goat Milk (Other)

Control

Experimental

Individuals who report being tolerant to both cow's milk and goat's milk.

Intervention: Cow milk (Other)

Cow milk intolerant

Experimental

Individuals who report being intolerant to cow's milk but not to goat's milk

Intervention: Goat Milk (Other)

Cow milk intolerant

Experimental

Individuals who report being intolerant to cow's milk but not to goat's milk

Intervention: Cow milk (Other)

Outcomes

Primary Outcomes

Digestive discomfort score from 0 to 8 hours post-meal

Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8 hours post-meal

A digestive tolerance questionnaire (Casellas, 2009) and a hunger sensation questionnaire using visual analog scales are administered hourly. These are based on scales from 1 to 10 to assess feelings of : flatulence, nausea, diarrhea, bloating, and abdominal pain.

Secondary Outcomes

  • 2H enrichment of plasma fatty acids from 0 to 8 hours post-meal(0, 1, 2, 3, 4, 5, 6, 7, 8 hours post-meal)
  • Intestinal microbiota composition(Once at the beginning of enrollement)
  • 15N enrichment of plasma and urine fractions from 0 to 8 hours post-meal(0, 1, 2, 3, 4, 5, 6, 7, 8 hours post-meal)
  • 2H enrichment of plasma glucose from 0 to 8 hours post-meal(0, 1, 2, 3, 4, 5, 6, 7, 8 hours post-meal)
  • Blood metabolites concentrations from 0 to 8 hours post-meal(0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 7, 8 hours post-meal)
  • Substrate oxidation rates from 0 to 8 hours post-meal(0, 1, 2, 3, 4, 5, 6, 7, 8 hours post-meal)
  • Exhaled breath gas concentrations from 0 to 8 hours post-meal(0, 1, 2, 3, 4, 5, 6, 7, 8 hours post-meal)

Investigators

Study Sites (1)

Loading locations...

Similar Trials